Deriving risks of Down's syndrome from nuchal translucency measurements
- PMID: 10658286
- DOI: 10.1046/j.1469-0705.1999.14060438.x
Deriving risks of Down's syndrome from nuchal translucency measurements
Comment on
-
A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.Ultrasound Obstet Gynecol. 1999 Apr;13(4):231-7. doi: 10.1046/j.1469-0705.1999.13040231.x. Ultrasound Obstet Gynecol. 1999. PMID: 10341399 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
